ATE72988T1 - Fettsaeure-zusammensetzungen. - Google Patents

Fettsaeure-zusammensetzungen.

Info

Publication number: ATE72988T1
Authority: AT; Austria
Prior art keywords: fatty acid; acid compositions; dgla; gla; cyclosporin
Prior art date: 1987-12-14

Application number

AT88311445T

Other languages

English (en)

Inventor

David Frederick Scoti Horrobin

Meadows Woodbridge

Original Assignee

Efamol Holdings

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-12-14

Filing date

1988-12-02

Publication date

1992-03-15

1988-12-02 Application filed by Efamol Holdings filed Critical Efamol Holdings

1992-03-15 Application granted granted Critical

1992-03-15 Publication of ATE72988T1 publication Critical patent/ATE72988T1/de

Links

239000000203 mixture Substances 0.000 title abstract 2
235000014113 dietary fatty acids Nutrition 0.000 title 1
229930195729 fatty acid Natural products 0.000 title 1
239000000194 fatty acid Substances 0.000 title 1
150000004665 fatty acids Chemical class 0.000 title 1
HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 abstract 1
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 abstract 1
229930105110 Cyclosporin A Natural products 0.000 abstract 1
108010036949 Cyclosporine Proteins 0.000 abstract 1
229960001265 ciclosporin Drugs 0.000 abstract 1
229930182912 cyclosporin Natural products 0.000 abstract 1
HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract 1
239000008024 pharmaceutical diluent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Transplantation (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Hematology (AREA)
Endocrinology (AREA)
Obesity (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Fats And Perfumes (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)

AT88311445T 1987-12-14 1988-12-02 Fettsaeure-zusammensetzungen. ATE72988T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB878729153A GB8729153D0 (en)	1987-12-14	1987-12-14	Fatty acid compositions
EP88311445A EP0321128B1 (de)	1987-12-14	1988-12-02	Fettsäure-Zusammensetzungen

Publications (1)

Publication Number	Publication Date
ATE72988T1 true ATE72988T1 (de)	1992-03-15

Family

ID=10628481

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT88311445T ATE72988T1 (de)	1987-12-14	1988-12-02	Fettsaeure-zusammensetzungen.

Country Status (15)

Country	Link
US (1)	US4970076A (de)
EP (1)	EP0321128B1 (de)
JP (1)	JP2722227B2 (de)
KR (1)	KR970010542B1 (de)
AT (1)	ATE72988T1 (de)
AU (1)	AU616713B2 (de)
CA (1)	CA1335789C (de)
DE (1)	DE3868886D1 (de)
ES (1)	ES2033442T3 (de)
GB (1)	GB8729153D0 (de)
GR (1)	GR3003991T3 (de)
HK (1)	HK129593A (de)
IE (1)	IE61698B1 (de)
NZ (1)	NZ227241A (de)
ZA (1)	ZA889269B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4750057A (en) *	1985-12-30	1988-06-07	Eastman Kodak Company	De-interlacing circuit for simultaneous readout of paired fields
CH679119A5 (de) *	1988-05-13	1991-12-31	Sandoz Ag
HU201567B (en) *	1988-07-21	1990-11-28	Gyogyszerkutato Intezet	Process for production of intravenous medical compositions containing cyclosphorin
GB8823621D0 (en) *	1988-10-07	1988-11-16	Madhok R	Compositions containing cyclosporins
JP3070611B2 (ja) *	1989-03-07	2000-07-31	サントリー株式会社	△▲上５▼―不飽和化酵素阻害剤
US5264217A (en) *	1990-01-30	1993-11-23	Efamol Holdings Ltd.	Method of increasing the total fat content of milk
GB9111900D0 (en) *	1991-06-03	1991-07-24	Efamol Holdings	Fatty acid compositions
CZ278863B6 (en) *	1992-09-07	1994-07-13	Galena	Medicinal preparations with n-methylated cyclic undecapeptides
US5716614A (en) *	1994-08-05	1998-02-10	Molecular/Structural Biotechnologies, Inc.	Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier
US5603951A (en) *	1994-11-09	1997-02-18	Hanmi Pharm. Ind. Co., Ltd.	Cyclosporin-containing soft capsule compositions
MY118354A (en)	1995-05-01	2004-10-30	Scarista Ltd	1,3-propane diol derivatives as bioactive compounds
USRE40546E1 (en) *	1996-05-01	2008-10-21	Scarista, Ltd.	1,3-Propane diol esters and ethers and methods for their use in drug delivery
ATE272055T1 (de) *	1995-05-01	2004-08-15	Scarista Ltd	Nicotinsäureester und diese enthaltende pharmazeutischen zusammensetzungen
US6696413B2 (en)	1995-06-16	2004-02-24	Hexal Ag	Pharmaceutical preparation with cyclosporin A
US5827822A (en) *	1996-03-25	1998-10-27	Sangstat Medical Corporation	Cyclosporin a formulations as nanoparticles
US5962019A (en) *	1995-08-25	1999-10-05	Sangstat Medical Corporation	Oral cyclosporin formulations
RU2172183C2 (ru) *	1995-08-25	2001-08-20	Сангстат Медикал Корпорейшн	Оральные циклоспориновые составы
US5766629A (en) *	1995-08-25	1998-06-16	Sangstat Medical Corporation	Oral cyclosporin formulations
US5834017A (en) *	1995-08-25	1998-11-10	Sangstat Medical Corporation	Oral cyclopsporin formulations
US20030220234A1 (en)	1998-11-02	2003-11-27	Selvaraj Naicker	Deuterated cyclosporine analogs and their use as immunodulating agents
KR100587551B1 (ko) *	1997-12-10	2006-06-08	싸이클로스포린 테라퓨틱스 리미티드	오메가-3 지방산 오일을 함유하는 약학 조성물
US6979456B1 (en)	1998-04-01	2005-12-27	Jagotec Ag	Anticancer compositions
NZ512287A (en)	1998-12-11	2002-12-20	Pharmasolutions Inc	Pharmaceutical compositions comprising a lipophilic drug in a propylene glycol ester of a higher fatty acid carrier, where 60% of the ester is a monoester
US6057289A (en) *	1999-04-30	2000-05-02	Pharmasolutions, Inc.	Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
US7732404B2 (en)	1999-12-30	2010-06-08	Dexcel Ltd	Pro-nanodispersion for the delivery of cyclosporin
DE60231570D1 (de)	2001-10-19	2009-04-23	Isotechnika Inc	Synthese von Cyclosporinanalogen
WO2004071510A1 (en) *	2003-02-11	2004-08-26	Cipla Ltd	Pharmaceutical composition comprising immunosuppressants for the treatment of dermatophytosis
US20050059583A1 (en)	2003-09-15	2005-03-17	Allergan, Inc.	Methods of providing therapeutic effects using cyclosporin components
US7345093B2 (en) *	2004-04-27	2008-03-18	Formatech, Inc.	Methods of enhancing solubility of compounds
GB0413729D0 (en) *	2004-06-18	2004-07-21	Tillotts Pharma Ag	A pharmaceutical composition and its use
US7135455B2 (en) *	2004-11-15	2006-11-14	Allergan, Inc	Methods for the therapeutic use of cyclosporine components
US7151085B2 (en) *	2004-11-15	2006-12-19	Allergan, Inc.	Therapeutic methods using cyclosporine components
DE102005061409A1 (de)	2005-12-22	2007-06-28	Robert Bosch Gmbh	Elektromagnetisch betätigbares Ventil
US20080058418A1 (en) *	2006-09-06	2008-03-06	The Coca-Cola Company	Stable polyunsaturated fatty acid emulsions and methods for inhibiting, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion
US20090018186A1 (en) *	2006-09-06	2009-01-15	The Coca-Cola Company	Stable beverage products comprising polyunsaturated fatty acid emulsions
GB0907413D0 (en)	2009-04-29	2009-06-10	Equateq Ltd	Novel methods
US10143652B2 (en)	2009-09-23	2018-12-04	Curirx Inc.	Methods for the preparation of liposomes
CA2781529C (en)	2009-09-23	2017-10-24	Indu Javeri	Methods for the preparation of liposomes comprising docetaxel
EP3556774B1 (de)	2011-03-11	2024-01-03	Beth Israel Deaconess Medical Center Inc.	Anti-cd40-antikörper und verwendungen davon
US8293790B2 (en)	2011-10-19	2012-10-23	Dignity Sciences Limited	Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
RU2714323C2 (ru)	2014-06-04	2020-02-14	ДиЭс БАЙОФАРМА ЛИМИТЕД	Фармацевтические композиции, содержащие дглк, и их применение
KR20250007054A (ko)	2015-09-04	2025-01-13	프리마토프 테라퓨틱스 인크.	인간화 항-cd40 항체 및 그의 용도
US20210315851A1 (en)	2020-04-03	2021-10-14	Afimmune Limited	Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4196189A (en) *	1977-03-19	1980-04-01	Blendax-Werke R. Schneider	Dental and oral hygiene preparations
ATE43335T1 (de) *	1980-02-14	1989-06-15	Sandoz Ag	Peptide die einen (1s,2r,3r)- oder (1r,2s,3s)-1nitrilo-1-carbonyl-3-methyl-2-oxyheptan oder hept-5-en-rest enthalten brauchbar in totaler synsthese von cyclosporinen, und verfahren zu ihrer herstellung.
AU1089683A (en) *	1982-02-08	1983-08-18	Smithkline Beckman Corporation	Antifungal composition
EP0087865B1 (de) *	1982-03-01	1986-10-01	Efamol Limited	Pharmazeutische Zusammensetzung
HU197733B (en) *	1985-05-29	1989-05-29	Chinoin Gyogyszer Es Vegyeszet	Process for producing ephedrin-salts of 7-oxo-prosta-cyclin derivatives
US4822606A (en) *	1986-04-07	1989-04-18	Duke University	Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
ATE80295T1 (de) *	1986-05-02	1992-09-15	Brigham & Womens Hospital	Fettsaeure und cyclosporin enthaltende zusammensetzung mit ermaessigter nephrotoxizitaet.

1987
- 1987-12-14 GB GB878729153A patent/GB8729153D0/en active Pending
1988
- 1988-12-02 DE DE8888311445T patent/DE3868886D1/de not_active Expired - Fee Related
- 1988-12-02 AT AT88311445T patent/ATE72988T1/de active
- 1988-12-02 ES ES88311445T patent/ES2033442T3/es not_active Expired - Lifetime
- 1988-12-02 EP EP88311445A patent/EP0321128B1/de not_active Expired - Lifetime
- 1988-12-05 IE IE362688A patent/IE61698B1/en not_active IP Right Cessation
- 1988-12-06 US US07/280,410 patent/US4970076A/en not_active Expired - Fee Related
- 1988-12-07 NZ NZ227241A patent/NZ227241A/en unknown
- 1988-12-07 CA CA000585187A patent/CA1335789C/en not_active Expired - Fee Related
- 1988-12-12 ZA ZA889269A patent/ZA889269B/xx unknown
- 1988-12-12 AU AU26778/88A patent/AU616713B2/en not_active Ceased
- 1988-12-14 JP JP63313986A patent/JP2722227B2/ja not_active Expired - Lifetime
- 1988-12-14 KR KR1019880016645A patent/KR970010542B1/ko not_active Expired - Fee Related
1992
- 1992-03-05 GR GR920400372T patent/GR3003991T3/el unknown
1993
- 1993-11-25 HK HK1295/93A patent/HK129593A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
US4970076A (en)	1990-11-13
NZ227241A (en)	1991-05-28
EP0321128A1 (de)	1989-06-21
IE883626L (en)	1989-06-14
DE3868886D1 (de)	1992-04-09
KR890009383A (ko)	1989-08-01
ES2033442T3 (es)	1996-07-16
JPH0276819A (ja)	1990-03-16
AU2677888A (en)	1989-06-15
HK129593A (en)	1993-12-03
CA1335789C (en)	1995-06-06
JP2722227B2 (ja)	1998-03-04
IE61698B1 (en)	1994-11-16
AU616713B2 (en)	1991-11-07
GB8729153D0 (en)	1988-01-27
GR3003991T3 (de)	1993-03-16
ZA889269B (en)	1989-08-30
KR970010542B1 (ko)	1997-06-28
EP0321128B1 (de)	1992-03-04

Publication	Publication Date	Title
DE3868886D1 (de)	1992-04-09	Fettsaeure-zusammensetzungen.
AU2206188A (en)	1989-05-11	Azithromycin and derivatives as antiprotozoal agents
IL86751A0 (en)	1988-11-30	Cyclosporins and pharmaceutical compositions containing them
ZA909762B (en)	1991-08-28	Process for the production of biologically active protein
ATE98125T1 (de)	1993-12-15	Zusammensetzungen essentieller fettsaeuren und therapie.
EP0334507A3 (de)	1991-04-17	Gamma-Linolensäure oder Dihomo-gamma-Linolensäure enthaltende Zubereitung zur Verbesserung der Haut
ATE81453T1 (de)	1992-10-15	Essentielle fettsaeure enthaltende zusammensetzungen.
EP0295954A3 (en)	1990-07-11	Compositions for the treatment of periodontal disease
EP0158212A3 (en)	1986-02-05	Citric-acid esters as blowing agents for working up plastics
GR3006807T3 (de)	1993-06-30
EP0179430A3 (en)	1987-07-01	Aqueous pharmaceutical formulations of piroxicam monohydrate
EP0293751A3 (en)	1990-07-25	Taurohyodeoxycholic acid for the therapy of calculosis of the biliary tract and of biliary dyspepsia
IL81800A0 (en)	1987-10-20	1,2,3,4-tetrahydro-6-substituted-4-aryl(or heterocyclo)-3-((substituted amino)carbonyl)-2-thioxo(or oxo)-5-pyrimidine-carboxylic acids and esters and pharmaceutical compositions containing the same
DK627687D0 (da)	1987-11-30	Hirudinvariant
FI884720A7 (fi)	1989-04-16	Varjoaineina käytettäviä koostumuksia
DE69108616D1 (de)	1995-05-11	3.3'-Dithiobis (Propionsäuren) und Estern davon.
NZ223293A (en)	1990-02-26	Beta-alkyl melatonins and pharmaceutical compositions
SE8800988L (sv)	1988-09-19	Farmaceutiska kompositioner med verkan paa hjaertat och det kardiovaskulaera systemet samt foerfarande foer framstaellning av desamma
IE882836L (en)	1989-03-18	Antiviral preparations
EP0303435A3 (en)	1990-01-03	Bipolar transistors
DE2965364D1 (en)	1983-06-16	Alpha-difluoromethyl amino acids and pharmaceutical composition containing the same
EP0468327A3 (en)	1992-08-26	Oral pharmaceutical compositions containing hirudin
EP0297816A3 (en)	1990-09-05	Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents
IT8748339A0 (it)	1987-09-01	Composizioni farmaceutiche ad atti vita'antineoplastica
MY101875A (en)	1992-02-15	Lankacidin derivatives and production thereof.